Income Statement (TTM)
Ocugen, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 2 | 3 | 3 | 7 | 6 | 7 | 7 | 5 | 4 | 5 | 5 |
| Change (%) | 0.00 | -100.00 | NaN | ∞ | 17.81 | 16.55 | 108.28 | -15.17 | 9.46 | 9.93 | -35.29 | -13.72 | 11.52 | 5.13 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | ||
| Cost Of Sales | 6 | 8 | 25 | 30 | 56 | 58 | 64 | 55 | 40 | 30 | 31 | 32 | 32 | 32 | 34 |
| Change (%) | 19.20 | 227.40 | 23.00 | 84.13 | 4.02 | 9.53 | -13.40 | -28.58 | -24.58 | 2.38 | 3.47 | 1.62 | 1.06 | 5.74 | |
| % of Revenue | 14,776.74 | 17,613.95 | 2,257.19 | 1,993.04 | 1,873.04 | 778.76 | 655.62 | 451.73 | 420.69 | 672.66 | 792.26 | 717.98 | 722.13 | ||
| Gross Operating Profit | -6 | -8 | -25 | -30 | -54 | -55 | -61 | -48 | -34 | -23 | -23 | -27 | -28 | -28 | -30 |
| Change (%) | 19.33 | 229.27 | 23.00 | 75.97 | 3.38 | 9.16 | -20.26 | -30.56 | -30.71 | 0.23 | 15.55 | 4.30 | -0.45 | 5.84 | |
| % of Revenue | -14,676.74 | -17,513.95 | -2,157.19 | -1,893.04 | -1,773.04 | -678.76 | -555.62 | -351.73 | -320.69 | -572.66 | -692.26 | -617.98 | -622.13 | ||
| SG&A | 8 | 10 | 15 | 18 | 35 | 34 | 34 | 34 | 32 | 30 | 28 | 26 | 27 | 27 | 26 |
| Change (%) | 23.93 | 50.37 | 20.22 | 98.16 | -5.12 | -0.02 | 1.44 | -6.08 | -5.94 | -5.86 | -9.89 | 4.54 | 0.18 | -3.45 | |
| % of Revenue | 18,544.19 | 22,981.40 | 1,422.83 | 1,145.92 | 983.02 | 478.78 | 530.05 | 455.46 | 390.05 | 543.13 | 658.10 | 591.22 | 542.95 | ||
| R&D | 6 | 2 | |||||||||||||
| Change (%) | |||||||||||||||
| % of Revenue | 96.58 | 52.23 | |||||||||||||
| OpEx | 14 | 17 | 40 | 48 | 92 | 92 | 98 | 89 | 72 | 66 | 59 | 57 | 59 | 62 | 60 |
| Change (%) | 21.83 | 127.18 | 21.96 | 89.31 | 0.48 | 6.04 | -8.29 | -20.01 | -7.33 | -11.21 | -2.96 | 2.92 | 4.68 | -2.31 | |
| % of Revenue | 33,320.93 | 40,595.35 | 3,680.02 | 3,138.96 | 2,856.06 | 1,257.54 | 1,185.67 | 1,003.77 | 810.74 | 1,215.79 | 1,450.36 | 1,361.43 | 1,265.08 | ||
| Operating Income | -14 | -17 | -40 | -48 | -89 | -89 | -94 | -82 | -66 | -60 | -52 | -52 | -55 | -57 | -55 |
| Change (%) | 21.90 | 127.74 | 21.96 | 84.17 | 0.00 | 5.70 | -12.52 | -20.43 | -8.88 | -13.55 | 1.59 | 4.41 | 4.17 | -2.90 | |
| % of Revenue | -33,220.93 | -40,495.35 | -3,580.02 | -3,038.96 | -2,756.06 | -1,157.54 | -1,085.67 | -903.77 | -710.74 | -1,115.79 | -1,350.36 | -1,261.43 | -1,165.08 | ||
| Interest Expense | -1 | -1 | -0 | -0 | -0 | -0 | -1 | -3 | |||||||
| Change (%) | -2.08 | -35.13 | -63.76 | -0.00 | 178.67 | ||||||||||
| % of Revenue | -1,676.74 | -1,641.86 | -0.34 | -0.53 | -20.21 | -53.58 | |||||||||
| Net Income | -22 | -25 | -47 | -48 | -87 | -86 | -90 | -80 | -63 | -58 | -50 | -51 | -54 | -57 | -57 |
| Change (%) | 14.36 | 89.51 | 0.59 | 82.46 | -0.80 | 4.17 | -11.38 | -20.66 | -8.56 | -13.50 | 2.51 | 5.69 | 6.34 | -0.94 | |
| % of Revenue | -50,748.84 | -58,034.88 | -3,488.91 | -2,937.94 | -2,626.02 | -1,117.36 | -1,045.03 | -872.95 | -686.92 | -1,088.17 | -1,333.02 | -1,271.12 | -1,197.71 | ||
Source: Capital IQ
